Moseley Investment Management Inc. Sells 49 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Moseley Investment Management Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,532 shares of the healthcare conglomerate’s stock after selling 49 shares during the quarter. Moseley Investment Management Inc.’s holdings in UnitedHealth Group were worth $1,281,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $32,000. Quarry LP grew its position in shares of UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the third quarter valued at approximately $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $543.76 on Wednesday. The firm’s fifty day moving average price is $554.45 and its two-hundred day moving average price is $563.12. The company has a market capitalization of $500.41 billion, a price-to-earnings ratio of 35.42, a P/E/G ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the business posted $6.56 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Barclays increased their target price on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.